Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome

Current pharmacologic treatment of the neonatal abstinence syndrome with morphine is associated with a lengthy duration of therapy and hospitalization. Buprenorphine may be more effective than morphine for this indication.

Read abstract ›

2018 Steering Committee Meeting

Stay in the loop!

Sign up to stay up to date with current content, news and events.